 ?您的位置：對照品 > 標(biāo)準(zhǔn)物質(zhì) > 一級標(biāo)準(zhǔn)物質(zhì) > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：F595736 |
| 產(chǎn)品名稱：2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-d5-ethyl]-4-methyl-3-oxo-pentanoic Acid, (2-Benzyloxy |
| 產(chǎn)品CAS：1020719-43-0 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
F595736 |
| 名稱: |
2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-d5-ethyl]-4-methyl-3-oxo-pentanoic Acid, (2-Benzyloxy-phenyl)-amide |
| 別名: |
4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-β-phenyl-N-[2-(phenylmethoxy)phenyl]benzenebutanamide-d5; |
| CAS號: |
1020719-43-0 |
| 參考CAS: |
類似: 887355-33-1 |
| 分子式: |
C??H??D?FNO? |
| 外觀: |
Light Yellow Foamy Solid |
| 分子量: |
528.62 |
| 溶解度: |
Acetone, Chloroform, Dichloromethane, Ethyl Acetate |
| 種類: |
Building Blocks; Isotopic Labeled Analogues; |
| 應(yīng)用: |
A deuterated intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
![2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-d5-ethyl]-4-methyl-3-oxo-pentanoic Acid, (2-Benzyloxy](/uploads/allimg/191202/1_120202433019E.png "2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-d5-ethyl]-4-methyl-3-oxo-pentanoic Acid, (2-Benzyloxy")
